Hormone-dependence of endometrial cancer
Gusberg, S.B.
Obstetrics and Gynecology 30(2): 287-293
1967
ISSN/ISBN: 0029-7844 PMID: 5212339 Document Number: 510752
The evidence for hormone-dependence in some endometrial cancers is substantial. Such evidence may be derived from the endometrial endpoint in certain clinical endocrine abnormalities, from animal experiments in susceptible species, and from human therapeutic responses. Further investigation in this field demands more expert epidemiologic analysis and more sophisticated study of steroid hormone-target cell relations.
Document emailed within 1 workday
Related Documents
Günthert, A.R.; Gründker, C.; Böttcher, B.; Emons, Günter. 2004: Luteinizing hormone-releasing hormone (LHRH) inhibits apoptosis induced by cytotoxic agent and UV-light but not apoptosis mediated through CD95 in human ovarian and endometrial cancer cells Anticancer Research 24(3a): 1727-1732Tavani, A.; La Vecchia, C.; Brinton, L.A.; McTiernan, A. 2001: Hormone replacement therapy and risk of endometrial cancer Tumori 87(5): S20-S21
Cook, L.S.; Dong, Y.; Round, P.; Huang, X.; Magliocco, A.M.; Friedenreich, C.M. 2014: Hormone contraception before the first birth and endometrial cancer risk Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 23(2): 356-361
1987: Combination oral contraceptive use and the risk of endometrial cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development JAMA 257(6): 796-800
Arteaga-Gómez, A.C.; Castellanos-Barroso, G.; Colin-Valenzuela, A.; García-Vargas, J.; Márquez-Acosta, G.; Reyes-Muñoz, E. 2011: Hormone therapy effect in postmenopausal women with history of endometrial cancer Ginecologia y Obstetricia de Mexico 79(1): 11-17
Magnusson, C.; Weiderpass, E. 2001: Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer Lakartidningen 98(5): 418-421
Audet-Lapointe, P.; Ayoub, J.; Methot, Y. 1988: An innovative protocol, cyclic hormone-chemotherapy in the treatment of high-risk localized endometrial cancer Journal de Gynecologie Obstetrique et Biologie de la Reproduction 17(6): 751-755
Chatzaki, E.; Bax, C.M.; Eidne, K.A.; Anderson, L.; Grudzinskas, J.G.; Gallagher, C.J. 1996: The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth factor Cancer Research 56(9): 2059-2065
Bergquist, C.; Nillius, S.J.; Wide, L.; Lindgren, A. 1981: Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception Fertility and Sterility 36(3): 339-342
Felix, A.S.; Gaudet, M.M.; La Vecchia, C.; Nagle, C.M.; Shu, X.O.; Weiderpass, E.; Adami, H.O.; Beresford, S.; Bernstein, L.; Chen, C.; Cook, L.S.; De Vivo, I.; Doherty, J.A.; Friedenreich, C.M.; Gapstur, S.M.; Hill, D.; Horn-Ross, P.L.; Lacey, J.V.; Levi, F.; Liang, X.; Lu, L.; Magliocco, A.; McCann, S.E.; Negri, E.; Olson, S.H.; Palmer, J.R.; Patel, A.V.; Petruzella, S.; Prescott, J.; Risch, H.A.; Rosenberg, L.; Sherman, M.E.; Spurdle, A.B.; Webb, P.M.; Wise, L.A.; Xiang, Y.-B.; Xu, W.; Yang, H.P.; Yu, H.; Zeleniuch-Jacquotte, A.; Brinton, L.A. 2015: Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium International Journal of Cancer 136(5): E410-E422
Neri, F.; Maggino, T. 2009: Surveillance of endometrial pathologies, especially for endometrial cancer, of breast cancer patients under tamoxifen treatment European Journal of Gynaecological Oncology 30(4): 357-360
Sany, O.; Singh, K.; Jha, S. 2012: Correlation between preoperative endometrial sampling and final endometrial cancer histology European Journal of Gynaecological Oncology 33(2): 142-144
Mangili, G.; De Marzi, P.; Viganò, R.; Rabaiotti, E.; Sassi, I.; Taccagni, G.L.; Garancini, P.; Frigerio, L. 2002: Identification of high risk patients with endometrial carcinoma. Prognostic assessment of endometrial cancer European Journal of Gynaecological Oncology 23(3): 216-220
Rzepka-Górska, I.; Bedner, R.; Cymbaluk-Płoska, A.; Chudecka-Głaz, A. 2008: Serum adiponectin in relation to endometrial cancer and endometrial hyperplasia with atypia in obese women European Journal of Gynaecological Oncology 29(6): 594-597
Hackenberg, R.; Loos, S.; Nia, A.H.; Kunzmann, R.; Schulz, K.D. 1998: Expression of placental protein 14 by the new endometrial cancer cell line MFE-280 in vitro and by endometrial carcinomas in vivo Anticancer Research 18(2a): 1153-1158
Broso, P. 1995: Cervico-vaginal and endometrial cytology in the screening for endometrial cancer Minerva Ginecologica 47(11): 503-507
Güven, M.A.; Pata, O.; Bakaris, S.; Kafkasli, A.; Mgoyi, L. 2004: Postmenopausal endometrial cancer screening: is there a correlation between transvaginal sonographic measurement of endometrial thickness and body mass index? European Journal of Gynaecological Oncology 25(3): 373-375
Prakansamut, N.; Sirayapiwat, P.; Triratanachat, S. 2014: The percentages of endometrial hyperplasia and endometrial cancer among polycystic ovary syndrome (PCOS) patients presenting with abnormal menstrual pattern Journal of the Medical Association of Thailand 97(2): 159-164
Guleria, K.; Agarwal, N.; Mishra, K.; Gulati, R.; Mehendiratta, A. 2004: Evaluation of endometrial steroid receptors and cell mitotic activity in women using copper intrauterine device: Can Cu-T prevent endometrial cancer? Journal of Obstetrics and Gynaecology Research 30(3): 181-187
Kahán, Z. 1996: Current questions about estrogen receptor determination and hormone dependence (does estrogen receptor positivity equal estrogen dependence?) Orvosi Hetilap 137(42): 2305-2308